Faculty Collaboration Database

Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency. J Immunol 1990 Mar 01;144(5):1721-8

Date

03/01/1990

Pubmed ID

2307837

Scopus ID

2-s2.0-0025324586 (requires institutional sign-in at Scopus site)   12 Citations

Abstract

Lymphocytes from children with severe combined immunodeficiency who had been immunologically reconstituted with haploidentical T cell-depleted bone marrow were analyzed with regard to their immunologic recognition of donor, host, or third party alloantigens. When compared with freshly isolated donor lymphocytes, the engrafted donor cells exhibited markedly reduced to absent responses toward host Ag in primary or secondary MLC and cell-mediated lympholysis assays. However, under limiting dilution conditions, cytotoxic responses to host Ag could be demonstrated, indicating that small numbers of host reactive cells were present, although down-regulated at high responder cell doses. These results are consistent with prior observations in limiting dilution cultures that indicate that cells with the potential to lyse autologous target cells exist in the peripheral blood of all normal individuals. The number of host reactive cells present in these patients is significantly less than that present in cells isolated directly from the marrow donors, and is also less than the number of autocytotoxic cells normally seen in peripheral blood. Together, these observations indicate that two mechanisms contribute to donor host tolerance in these patients. The majority of host reactive cells appear to have undergone clonal deletion or inactivation, whereas the small residual host-reactive population appears to be under ongoing immunoregulatory control.

Author List

Rosenkrantz K, Keever C, Bhimani K, Horvath A, Brochstein J, O'Reilly R, Dupont B, Flomenberg N

MESH terms used to index this publication - Major topics in bold

Bone Marrow Transplantation
Cell Survival
Clone Cells
Graft Survival
HLA Antigens
Histocompatibility
Humans
Immune Tolerance
Immunologic Deficiency Syndromes
Lymphocyte Activation
Male